MitoImmune Therapeutics Inc.

MitoImmune Therapeutics Inc. is a drug discovery and development biotech company that harnesses the power of mitochondria and its proprietary technology targeting mitochondria as the source for developing new potential breakthrough therapeutics. Our mission is to increase healthy lifespan by developing treatments for mitochondrial dysfunction-related necrotic and inflammatory diseases.